1. Home
  2. STOK vs ARCO Comparison

STOK vs ARCO Comparison

Compare STOK & ARCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • ARCO
  • Stock Information
  • Founded
  • STOK 2014
  • ARCO 2007
  • Country
  • STOK United States
  • ARCO Uruguay
  • Employees
  • STOK N/A
  • ARCO N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • ARCO Restaurants
  • Sector
  • STOK Health Care
  • ARCO Consumer Discretionary
  • Exchange
  • STOK Nasdaq
  • ARCO Nasdaq
  • Market Cap
  • STOK 1.3B
  • ARCO 1.5B
  • IPO Year
  • STOK 2019
  • ARCO 2011
  • Fundamental
  • Price
  • STOK $31.97
  • ARCO $7.21
  • Analyst Decision
  • STOK Strong Buy
  • ARCO Hold
  • Analyst Count
  • STOK 7
  • ARCO 1
  • Target Price
  • STOK $30.83
  • ARCO $8.80
  • AVG Volume (30 Days)
  • STOK 1.5M
  • ARCO 1.1M
  • Earning Date
  • STOK 11-12-2025
  • ARCO 11-12-2025
  • Dividend Yield
  • STOK N/A
  • ARCO 3.33%
  • EPS Growth
  • STOK N/A
  • ARCO N/A
  • EPS
  • STOK 0.91
  • ARCO 0.62
  • Revenue
  • STOK $199,893,000.00
  • ARCO $4,496,793,000.00
  • Revenue This Year
  • STOK $416.54
  • ARCO $7.09
  • Revenue Next Year
  • STOK N/A
  • ARCO $7.58
  • P/E Ratio
  • STOK $35.55
  • ARCO $11.66
  • Revenue Growth
  • STOK 1218.82
  • ARCO 0.09
  • 52 Week Low
  • STOK $5.35
  • ARCO $6.51
  • 52 Week High
  • STOK $38.69
  • ARCO $9.33
  • Technical
  • Relative Strength Index (RSI)
  • STOK 62.96
  • ARCO 62.68
  • Support Level
  • STOK $31.19
  • ARCO $6.90
  • Resistance Level
  • STOK $34.86
  • ARCO $7.13
  • Average True Range (ATR)
  • STOK 2.77
  • ARCO 0.15
  • MACD
  • STOK -0.28
  • ARCO 0.04
  • Stochastic Oscillator
  • STOK 46.19
  • ARCO 88.15

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About ARCO Arcos Dorados Holdings Inc. Shares

Arcos Dorados Holdings Inc operates McDonald's branded restaurants in various countries and territories in Latin America and the Caribbean. The Company manages its business as distinct geographic segments and its operations are divided into three geographic divisions, as follows: Brazil, the North Latin American division, or NOLAD, which is comprised of Costa Rica, Mexico, Panama, Puerto Rico, Martinique, Guadeloupe, French Guiana and the U.S. Virgin Islands of St. Croix and St. Thomas and the South Latin American division, or SLAD, which is comprised of Argentina, Chile, Ecuador, Peru, Uruguay, Colombia, Venezuela, Trinidad and Tobago, Aruba and Curacao. Their menu includes hamburgers, McNuggets, salad, sandwiches, French fries, and others.

Share on Social Networks: